Zeria Pharmaceutical Co., Ltd. (TSE:4559) announces a share repurchase program. Under the program, the company will repurchase up to 800,000 shares, representing 1.8% of its issued share capital (excluding treasury stock), for a total purchase price of ¥1,800 million. The purpose of the program is to carry out agile capital policies in response to changes in the environment.

The program will be valid till November 4, 2022. As of end of April 2022, the company had 44,344,368 issued shares (excluding treasury stock) and 8,774,822 treasury shares.